Immunoprecise Antibodies Ltd IPA

Healthcare Biotechnology

ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.

NDAQ:IPA - Post by User

Immunoprecise Antibodies Ltd

<< Previous

Bullboard Posts

Next >>

Post by bmreedon Jul 26, 2023 5:10pm

144 Views

Post# 35558472

Webinar Recap w $IPA CEO Jennifer Bath & Radius Research

Webinar Recap: Immunoprecise Antibodies $IPA w CEO Jennifer Bath - Pitch, Deep Dive and Q&A - https://youtu.be/WJhkiouXF1c

CEO Jennifer Bath discusses IPA's technology platform using biology, multi-omics modelling and Artificial Intelligence and it's commercialization and market development strategy.